Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Influenza Virus
100%
Drug Candidates
100%
Neuraminidase
100%
Computational Design
100%
Virus Subtypes
100%
Viral Neuraminidase
100%
H1N1 Subtype
100%
Cysteine
66%
Arginine
50%
Proline
50%
Tyrosine
33%
Methionine
33%
Cyclization
33%
Cystein
33%
Molecular Docking
16%
Binding Energy
16%
Hydrogen Bonding Interaction
16%
Molecular Dynamics
16%
Potential Alternatives
16%
High Specificity
16%
Protease Enzyme
16%
High Activity
16%
Digestion
16%
Oral Bioavailability
16%
Potential Inhibitors
16%
Computational Methods
16%
Polypeptide
16%
Disulfide Bridge
16%
Peptide Ligand
16%
Phenylalanine
16%
Residual Interaction
16%
Dynamic Progress
16%
Peptide Stability
16%
H1N1 Infection
16%
Sigma-1 Receptor
16%
Peptide Drug Design
16%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
Influenza A Virus (H1N1)
100%
Viral Neuraminidase
100%
Cysteine
100%
Virus
100%
Sialidase
83%
Neuraminidase
83%
Arginine
50%
Proline
50%
Tyrosine
33%
Methionine
33%
Peptide
33%
Docking (Molecular)
16%
Binding Energy
16%
Disulfide
16%
Peptide Stability
16%
Protease
16%
Phenylalanine
16%
Receptor Binding
16%
Drug Development
16%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza A Virus (H1N1)
100%
Influenza
100%
Cysteine
100%
Enzymes
100%
Sialidase
100%
Virus
100%
Arginine
50%
Proline
50%
Methionine
33%
Tyrosine
33%
Peptide
33%
Receptor
16%
Infection
16%
Drug Development
16%
Bioavailability
16%
Proteinase
16%
Disulfide
16%
Hydrogen
16%
Phenylalanine
16%
Polypeptide
16%
Peptide Stability
16%
Chemistry
Cysteine
100%
Proline
50%
Arginine
50%
Methionine
33%
Peptide
33%
Tyrosine
33%
Hydrogen Bonding
16%
Molecular Dynamics
16%
Carcinogenic
16%
Binding Energy
16%
Bioavailability
16%
Disulfide
16%
formation
16%
mutagenic
16%
Peptide Stability
16%
Phenylalanine
16%
Polypeptide
16%
Molecular Docking
16%